IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Chemopreventive and Therapeutic Potential of Phytopharmaceuticals Against Oral Cancer: Evidence-Based Reports From Preclinical Studies in Animal Models

Chemopreventive and Therapeutic Potential of Phytopharmaceuticals Against Oral Cancer: Evidence-Based Reports From Preclinical Studies in Animal Models
View Sample PDF
Author(s): Dharmeswar Barhoi (Assam University, Silchar, India), Sarbani Giri (Assam University, Silchar, India), Puja Upadhaya (Assam University, Silchar, India) and Sweety Nath Barbhuiya (Assam University, Silchar, India)
Copyright: 2021
Pages: 29
Source title: Handbook of Research on Advancements in Cancer Therapeutics
Source Author(s)/Editor(s): Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India) and Saurabh Verma (National Institute of Pathology, India)
DOI: 10.4018/978-1-7998-6530-8.ch020

Purchase


Abstract

Oral cancer is a major public health problem in both developing and developed countries. It is believed to be the eighth most common cancer considering a major risk factor of worldwide morbidity and mortality. Major risk factors of this deadly disease are lifestyle (consumption of smoking and smokeless tobacco, alcohol, betel quid, etc.), unhealthy food, and poor dental care and viral infections. These factors are responsible for mutations in the DNA leading to the initiation of carcinogenesis. Oral carcinogenesis is a multistep process having three distinct phases: initiation, promotion, and progression. Modern cancer treatments (chemotherapy, surgery, radiation therapy, and immunotherapy) are associated with lots of side effects. Thus, phytopharmaceuticals are being used as alternative medicines in the prevention of oral carcinogenesis. Phytopharmaceuticals (such as resveratrol, sulforaphane, quercetin, etc.) have immense potential to prevent cancer development in every phase of carcinogenesis and more importantly, these compounds have fewer side effects.

Related Content

Mayuree Tangkiatkumjai. © 2022. 12 pages.
Dawn-Marie Walker, Mayuree Tangkiatkumjai. © 2022. 13 pages.
G. Ramadhas, A.S. Suman Sankar, N.V. Sugathan. © 2022. 17 pages.
Aashaq Hussain Bhat, Himani Goyal Sharma. © 2022. 19 pages.
Kiran Mustafa, Javaria Kanwal, Sara Musaddiq, Samia Khakwani. © 2022. 14 pages.
Sreekumari Kurissery, Leah Katherine Shaw, Nandakumar Kanavillil. © 2022. 25 pages.
Ankita Gautam. © 2022. 18 pages.
Body Bottom